Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$143M |
| 2 |
WNR
Western Refining Inc
WNR
|
+$142M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$137M |
| 4 |
BHI
Baker Hughes
BHI
|
+$135M |
| 5 |
POM
PEPCO HOLDINGS, INC.
POM
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$215M |
| 2 |
LSI
LSI CORPORATION
LSI
|
+$185M |
| 3 |
Omnicom Group
OMC
|
+$165M |
| 4 |
BRE
BRE PROPERTIES INC CL A
BRE
|
+$95M |
| 5 |
JOSB
JOS A BANK CLOTHIERS INC
JOSB
|
+$83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.95% |
| 2 | Technology | 13.55% |
| 3 | Financials | 10.47% |
| 4 | Energy | 10.33% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
RTX Corp
RTX
$283B
| $60.4M | 0.16% |
831,174
+246,613
| +42% | +$18.2M |
|
|
CMA
152
DELISTED
Comerica
CMA
| $59.7M | 0.16% |
1,190,548
-74,900
| -6% | -$3.66M |
|
153
First Solar
FSLR
$23B
| $59.5M | 0.16% |
837,751
-638,909
| -43% | -$42.3M |
|
154
Comcast
CMCSA
$95.3B
| $58.6M | 0.16% |
2,182,986
-1,268,800
| -37% | -$32.6M |
|
|
FLIR
155
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $58.5M | 0.16% |
1,685,438
+183,000
| +12% | +$6.41M |
|
|
CTXS
156
DELISTED
Citrix Systems Inc
CTXS
| $58.3M | 0.16% |
1,171,118
+251,663
| +27% | +$12.1M |
|
157
Timken Company
TKR
$8.67B
| $58.2M | 0.16% |
1,199,344
-73,482
| -6% | -$3.33M |
|
158
ITT
ITT
$18.6B
| $58.1M | 0.16% |
1,208,497
+92,100
| +8% | +$4.1M |
|
159
Micron Technology
MU
$1.09T
| $58.1M | 0.16% |
1,762,890
+1,085,600
| +160% | +$29.6M |
|
160
Colgate-Palmolive
CL
$72.6B
| $58M | 0.16% |
850,074
+31,100
| +4% | +$2.08M |
|
|
DISH
161
DELISTED
DISH Network Corp.
DISH
| $58M | 0.16% |
890,564
+412,000
| +86% | +$24.8M |
|
162
Lockheed Martin
LMT
$130B
| $57.6M | 0.16% |
358,212
+99,750
| +39% | +$16.2M |
|
163
Reliance Steel & Aluminium
RS
$19.8B
| $56.8M | 0.15% |
770,727
-5,600
| -0.7% | -$402K |
|
|
CA
164
DELISTED
CA, Inc.
CA
| $56.5M | 0.15% |
1,967,172
-327,600
| -14% | -$9.69M |
|
|
SWN
165
DELISTED
Southwestern Energy Company
SWN
| $56.4M | 0.15% |
1,240,828
+1,182,188
| +2,016% | +$54.8M |
|
|
SPN
166
DELISTED
Superior Energy Services, Inc.
SPN
| $56.2M | 0.15% |
155,463
+4,280
| +3% | +$1.42M |
|
167
Lam Research
LRCX
$393B
| $55.8M | 0.15% |
8,257,990
+2,445,000
| +42% | +$14.6M |
|
|
TW
168
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $55.6M | 0.15% |
533,306
+26,000
| +5% | +$2.84M |
|
169
Patterson-UTI
PTEN
$4.71B
| $55.6M | 0.15% |
1,590,548
+577,100
| +57% | +$18.9M |
|
170
Capital One
COF
$134B
| $55.3M | 0.15% |
668,997
+248,868
| +59% | +$19.3M |
|
171
O-I Glass
OI
$1.1B
| $55.2M | 0.15% |
1,592,403
-164,100
| -9% | -$5.43M |
|
|
DCUB
172
DELISTED
DOMINION RESOURCES INC CORP UNIT 2013 SER B (VA)
DCUB
| $55.1M | 0.15% |
948,450
+242,350
| +34% | +$14M |
|
173
Myriad Genetics
MYGN
$306M
| $55.1M | 0.15% |
1,414,720
+28,954
| +2% | +$1.08M |
|
|
HNT
174
DELISTED
HEALTH NET INC
HNT
| $54.5M | 0.15% |
1,311,000
+176,634
| +16% | +$6.58M |
|
175
Parker-Hannifin
PH
$126B
| $54.2M | 0.15% |
430,903
+85,300
| +25% | +$10.6M |
|
Similar funds
Cliff Asness's Q2 2014 Portfolio in Review
As of Q2 2014, Cliff Asness held 2,714 positions worth $37.1B, up 12% from $33.1B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Cliff Asness's Q2 2014 filing shows 178 new, 1,030 increased, 953 reduced and 205 closed positions. Its largest new stake was AstraZeneca: 1,186,418 shares worth $88.2M. The largest sale was BEAM INC COM STK (DE), an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Cliff Asness's largest Q2 2014 buy was AstraZeneca: 1,186,418 shares worth $88.2M.
- Cliff Asness added most to EOG Resources in Q2 2014, an estimated $143M increase.
- Cliff Asness's biggest Q2 2014 reduction was Omnicom Group, cutting an estimated $165M.
- Cliff Asness fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $215M.
- Cliff Asness's ten largest holdings make up 8.6% of its $37.1B portfolio in Q2 2014.
- Cliff Asness opened 178 new positions and closed 205 in Q2 2014.
- Cliff Asness's portfolio value rose 12% quarter-over-quarter to $37.1B.
Based on AQR Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.